Clinical Trial Update: Identification of New Markers in the Hypereosinophilic Syndrome [NA]

View source ↗

Summary

This completed clinical trial explored identification of new biomarkers for hypereosinophilic syndrome. The study was conducted at University Hospital, Lille.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypereosinophilic Syndrome

Snippet

Sponsor: University Hospital, Lille | Conditions: Hypereosinophilic Syndrome | NA | Status: COMPLETED